Benzinga's Volume Movers (HGSI, GMCR, SMTC, SBUX)

Human Genome Sciences Inc HGSI shares moved up 9.64% to $28.16 at 10:45 am. The volume of HGSI shares traded was 2533% higher than normal. GlaxoSmithKline Plc GSK and HGSI received the Food and Drug Administration (FDA) approval for Benlysta, the first new drug to treat lupus in over 50 years.

Green Mountain Coffee Roasters Inc GMCR shares rose 26.95% to $55.40. The volume of GMCR shares traded was 981% higher than normal. GMCR agreed to sell Starbucks Corp's SBUX coffee and Tazo teas pods for its popular Keurig machines.

Semtech Corporation SMTC shares climbed 9.42% to $24.62. The volume of SMTC shares traded was 464% higher than normal. SMTC reported upbeat Q4 results.

Starbucks Corp SBUX shares gained 8.14% to $37.35. The volume of SBUX shares traded was 405% higher than normal. Green Mountain Coffee Roasters agreed to sell SBUX's coffee and Tazo teas pods for its popular Keurig machines.

Read more from Benzinga's Markets.